Managing Patients on SGLT2 Inhibitors in Primary Care

Area of Science:

• Cardiology
• Endocrinology
• Primary Care Medicine

Background:

• Sodium-glucose co-transporter 2 (SGLT2) inhibitors are increasingly prescribed for cardiovascular and renal benefits.
• Primary care physicians require guidance on managing patients initiating SGLT2 inhibitor therapy.

Purpose of the Study:

• To provide practical insights into the management of patients on SGLT2 inhibitors within primary care.
• To highlight key considerations for initiating and monitoring SGLT2 inhibitor treatment.

Main Methods:

• Expert discussion and clinical case examples.
• Focus on real-world application in primary care settings.

Main Results:

• Discussion covers patient selection, dosage titration, and potential side effects.
• Emphasis on integrating SGLT2 inhibitors into existing treatment regimens.

Conclusions:

• Effective management of SGLT2 inhibitors in primary care is achievable with appropriate knowledge.
• Optimizing SGLT2 inhibitor use can improve patient outcomes.